| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |